Chiome Bioscience Inc. announced consolidated earnings results for the six months ended June 30, 2018. For the six months, the company reported net sales of JPY 92 million against JPY 102 million a year ago. Operating loss was JPY 607 million against JPY 388 million a year ago. Ordinary loss was JPY 603 million against JPY 389 million a year ago. Net loss was JPY 603 million against JPY 389 million a year ago. Net loss per share was JPY 22.55 against JPY 15.02 a year ago. Loss before taxes was JPY 602.71 million against JPY 388.32 million a year ago. Net cash used in operating activities of JPY 690.43 million against JPY 385.89 million a year ago.